PPARγ agonists enhance ET-743–induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma

Ecteinascidin 743 Interferes with the Activity of EWS-FLI1 in Ewing Sarcoma Cells

(2015) Patrick J. Grohar et al.   NEOPLASIA

Comparative Epigenomic Analysis of Murine and Human Adipogenesis

(2010) Tarjei S. Mikkelsen et al.   CELL

Functional Mapping of Receptor Tyrosine Kinases in Myxoid Liposarcoma

(2010) T. Negri et al.   CLINICAL CANCER RESEARCH

Novel Models of Myxoid Liposarcoma Xenografts Mimicking the Biological and Pharmacologic Features of Human Tumors

(2010) R. Frapolli et al.   CLINICAL CANCER RESEARCH

A Review of Trabectedin (ET-743): A Unique Mechanism of Action

(2010) Maurizio D'Incalci et al.   MOLECULAR CANCER THERAPEUTICS

FUS-CHOP Fusion Protein Expression Coupled to p53 Deficiency Induces Liposarcoma in Mouse but Not in Human Adipose-Derived Mesenchymal Stem/Stromal Cells

(2010) Rene Rodriguez et al.   STEM CELLS

Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series

(2009) F. Grosso et al.   ANNALS OF ONCOLOGY

Characterization and comparison of the properties of sarcoma cell linesin vitroandin vivo

(2009) Joslyn MILLS et al.   Human Cell

Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors

(2009) C. Forni et al.   MOLECULAR CANCER THERAPEUTICS

A Developmental Model of Sarcomagenesis Defines a Differentiation-Based Classification for Liposarcomas

(2008) Igor Matushansky et al.   AMERICAN JOURNAL OF PATHOLOGY

EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells

(2008) N. Riggi et al.   CANCER RESEARCH

Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin

(2008) G. D. Girnun et al.   CLINICAL CANCER RESEARCH

FUS-DDIT3 Prevents the Development of Adipocytic Precursors in Liposarcoma by Repressing PPARγ and C/EBPα and Activating eIF4E

(2008) Pedro A. Pérez-Mancera et al.   PLoS One